Syra Health Corp.
SYRA Healthcare Medical Care Facilities
Syra Health Corp.’s revenue for fiscal 2025 (year ended December 2025) was $7.2 million, down 9.47% from fiscal 2024. In the quarter to June 2026, revenue grew 23.0%, EPS grew 477.4% and free cash flow fell 892.7%, each against the same quarter a year earlier.
Follow SYRA
Syra Health Corp. (SYRA) P/E ratio
As of 16 October 2026, Syra Health Corp. (SYRA) trades at a P/E ratio of 84.0×. Over the past ten years it has ranged from 0.0× (June 2026) to 105× (July 2026); the current reading is higher than 95% of that period. That is above the Medical Care Facilities industry median of 20.6× and above the Healthcare sector median of 23.0×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 64.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 11 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| NVOS Novo Integrated Sciences, Inc. compare | n/m |
| CANOQ Cano Health, Inc. compare | n/m |
| BACK IMAC Holdings, Inc. compare | n/m |
| MODVQ ModivCare Inc. compare | n/m |
| IONM Assure Holdings Corp. compare | n/m |
| RHEP Adcare Health Systems Inc compare | 0.6× |
| SYRA Syra Health Corp. | 84.0× |
| NIVF NewGenIvf Group Limited compare | — |
| BMGL Basel Medical Group Ltd compare | — |
| Medical Care Facilities industry median | 20.6× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)